Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.93%23.06B | -5.72%15.22B | -9.45%9.7B | -3.63%4.8B | 7.46%24B | 7.33%16.14B | 11.31%10.71B | 15.77%4.99B | -5.74%22.34B | -7.80%15.04B |
| Operating income | -3.93%23.06B | -5.72%15.22B | -9.45%9.7B | -3.63%4.8B | 7.46%24B | 7.33%16.14B | 11.31%10.71B | 15.77%4.99B | -5.74%22.34B | -7.80%15.04B |
| Operating expenses | 5.39%-19.94B | 8.52%-13.5B | 10.72%-8.65B | 3.06%-4.38B | -3.40%-21.07B | -10.08%-14.76B | -12.91%-9.68B | -16.81%-4.51B | 1.42%-20.38B | 8.48%-13.41B |
| Gross profit | 6.55%3.12B | 24.21%1.72B | 2.50%1.05B | -9.07%428.16M | 49.71%2.93B | -15.27%1.38B | -1.82%1.03B | 6.70%470.86M | -35.28%1.96B | -1.80%1.63B |
| Selling expenses | -6.92%-142.38M | 6.35%-86.99M | 15.25%-50.93M | 20.54%-22.59M | 5.62%-133.16M | -14.02%-92.88M | -19.58%-60.1M | -27.27%-28.43M | -18.30%-141.09M | -9.52%-81.46M |
| Administrative expenses | -7.84%-1.06B | 5.06%-662.88M | 10.87%-419.69M | 9.54%-211.57M | 13.00%-987.17M | -0.18%-698.2M | -1.13%-470.89M | 1.89%-233.87M | -6.14%-1.13B | 4.81%-696.97M |
| Research and development expenses | 0.42%-956.97M | -2.24%-532.14M | 9.98%-284.06M | -13.10%-122.96M | -1.88%-961.03M | -5.06%-520.51M | 1.54%-315.56M | 23.10%-108.72M | -3.43%-943.31M | -10.67%-495.45M |
| Profit from asset sales | 27,564.08%28.49M | 9,486.87%28.47M | 17,258.54%28.47M | 38,468.92%28.54M | 105.24%103K | -92.46%297K | -93.59%164K | 89.74%74K | -333.89%-1.97M | 656.24%3.94M |
| Revaluation surplus | ---- | ---- | ---- | ---- | 857.31%4.84M | --4.84M | --4.84M | --4.84M | --506K | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | 857.31%4.84M | --4.84M | --4.84M | --4.84M | --506K | ---- |
| Impairment and provision | 40.34%-147.98M | -81.07%92.57M | -50.31%91.06M | 44.82%92.53M | 89.47%-248.03M | 146.26%488.99M | 117.01%183.24M | -44.07%63.9M | -504.02%-2.35B | -443.48%-1.06B |
| -Other impairment is provision | 40.34%-147.98M | -81.07%92.57M | -50.31%91.06M | 44.82%92.53M | 89.47%-248.03M | 146.26%488.99M | 117.01%183.24M | -44.07%63.9M | -504.02%-2.35B | -443.48%-1.06B |
| Special items of operating profit | -231.41%-42.09M | -52.61%22.93M | -90.17%3.88M | -95.98%1.03M | -24.25%32.03M | 261.41%48.39M | 362.69%39.51M | 476.12%25.65M | -74.66%42.28M | -18.11%13.39M |
| Adjustment items of operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2K | ---- | ---- |
| Operating profit | 29.04%687.91M | -5.44%506.7M | 3.65%368.99M | -1.48%167.28M | 119.81%533.09M | 170.23%535.84M | 139.14%355.99M | 26.72%169.79M | -559.30%-2.69B | -217.42%-762.95M |
| Financing income | -34.25%79.53M | -63.20%24.89M | -52.46%14.07M | 2.46%7.37M | -11.38%120.96M | -36.09%67.65M | -66.18%29.6M | -86.84%7.19M | -19.03%136.5M | 27.08%105.85M |
| Financing cost | 24.76%-263.25M | 24.54%-191.75M | 15.52%-132.77M | 5.46%-66.37M | 12.47%-349.86M | 13.66%-254.1M | 22.09%-157.16M | 38.96%-70.2M | 19.07%-399.7M | 18.14%-294.3M |
| Special items of earning before tax | -18.12%80.36M | -78.67%9.77M | -79.57%3.75M | -135.21%-1.8M | 1,700.26%98.13M | 652.41%45.8M | 506.23%18.33M | 855.97%5.12M | 140.13%5.45M | 70.98%-8.29M |
| Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | --1K |
| Earning before tax | 3.96%454.19M | -22.36%302.86M | -12.63%235.32M | -19.31%106.22M | 114.84%436.9M | 143.96%390.11M | 128.45%269.33M | 73.74%131.63M | -1,133.39%-2.94B | -360.93%-887.47M |
| After-tax profit from continuing operations | 41.96%380.9M | -22.83%229.27M | -12.43%174.34M | -26.52%84.68M | 109.47%268.31M | 140.14%297.09M | 124.40%199.09M | 153.35%115.25M | -1,483.58%-2.83B | -395.63%-740.23M |
| Adjustment items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.85M |
| Earning after tax | 41.96%380.9M | -22.83%229.27M | -12.43%174.34M | -26.52%84.68M | 109.47%268.31M | 140.14%297.09M | 124.40%199.09M | 153.35%115.25M | -1,483.58%-2.83B | -395.63%-740.23M |
| Minority profit | 161.60%123.29M | 140.64%110.4M | 66.46%71.75M | 67.35%18.89M | 126.77%47.13M | 83.51%45.88M | 184.48%43.11M | -73.43%11.29M | -290.60%-176.06M | -74.62%25M |
| Profit attributable to shareholders | 16.47%257.61M | -52.68%118.88M | -34.23%102.59M | -36.71%65.8M | 108.32%221.18M | 132.83%251.22M | 118.77%155.99M | 3,343.56%103.96M | -2,463.52%-2.66B | -603.88%-765.23M |
| Basic earnings per share | 91.58%0.0364 | -81.47%0.0078 | -55.00%0.009 | -50.26%0.0094 | 102.12%0.019 | 115.14%0.0421 | 106.67%0.02 | 1,475.00%0.0189 | -24,850.00%-0.8982 | -656.00%-0.278 |
| Diluted earnings per share | 93.62%0.0364 | -81.47%0.0078 | -55.00%0.009 | 0.0094 | 102.09%0.0188 | 115.14%0.0421 | 0.02 | -0.8982 | -0.278 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.